中文ENGLISH
分享到 

R&D center

HOME > 研发中心 > 研发策略

研发中心

研发中心

Research key

Haisco R&D Center focus on high-end Parenteral nutrition, anti-infectious, Hepatobiliary diseases area. And we successfully developed more than 10 novel products and took over the leading position of related fields in Mainland China. At present, the key point of R&D Center is focusing on three areas:

Innovative generic drugs

R&D Center utilizes model technology to modify the original product process, obtain innovative achievements such as new synthetic routes, new salts and new crystal forms, make breakthroughs among complicate patent network, avoid the original patent as well as apply for exclusive innovation patent. For those programs with high technical barrier, high investment and long R&D cycle such as multi chamber bag of parenteral nutrition preparation, oral sustained and controlled release preparations, R&D Center established systematic core competency by systematic and multi-fields integrated research. Depended on the technology accumulation and high-efficiency R&D management experience after years, by now, Center has initiated more than 20 projects in cardiovascular and cerebrovascular diseases, high-end parenteral nutrition and diabetes areas, while some of them already achieved breakthrough and are about to enter IND filing.



Small molecular patent medicine

Small molecular patent medicine research of R&D Center is focus on anticoagulant, Sedative and hypnotic and antineoplastic. At present, Center has built up or will build up the Me-too and Me-better innovative drug research platform in those fields. Meanwhile, Center has initialed two patent innovative drug development in anticoagulant, Sedative and hypnotic area, pushing Haisco forward to be the idiomatical professional small molecular patent medicine developing company.

Mono-clone antibody biotech drugs

R&D Center forms several teams which in charge of mono-clone antibody biotech drugs Project approval, research management and quality control. Through the cooperation with CRO company, Center specially initialed the project of the monoclonal antibody research for anticancer, at the same time, tackle key problems in cell line construction, process optimization, extraction and separation and quality control, leading Haisco march in biotech drugs field.

By now, R&D Center has independent generic drug research facility, patent medicine research facility and pilot-scale experiment base. The laboratory can undertake materials process research, preparation technology research, quality standard research projects; the pilot-scale experiment base includes oral drug preparation semi-works and multi chamber bag injection multi semi-works, which can undertake the pilot study of some complicate technology new products such as multi chamber bag of parenteral nutrition preparation, sustained and controlled release preparations. R&D Center also outfits with hundreds of advanced research equipments, including NMR spectrometer, Mass spectrometers, gas chromatograph-mass spectrometer (GC-MS), HPLC, Atomic Absorption Spectrometer, Emulsion particle detecting instrument, ultraviolet spectrophotometer, infrared spectrophotometer, High pressure homogenizer, enzyme-labeled instrument and so on. The research capability of R&D Center is on the domestic leading level, promoting the research specialist staff’s innovation research on key areas.